lncRNA UCA1 Functions as a ceRNA to Promote Prostate Cancer Progression via Sponging miR143

被引:78
|
作者
Yu, Yanlan [1 ]
Gao, Fengbin [1 ]
He, Qian [1 ]
Li, Gonghui [1 ]
Ding, Guoqing [1 ]
机构
[1] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Urol, Sch Med, Hangzhou 310016, Peoples R China
来源
关键词
LONG NONCODING RNA; METASTASIS; CARCINOMA;
D O I
10.1016/j.omtn.2019.11.021
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
UCA1 (urothelial carcinoma associated 1) is a long non-coding RNA (lncRNA) that was found overexpressed in various human cancers including prostate cancer (PCa). However, the aspect of UCA 1 -miRNA-mRNA interaction in PCa remains unclear. In this study, we confirmed the role of UCA1 in PCa and found that UCA1 downregulation inhibited cell proliferation of PCa cells. Then we demonstrated that repressed UCA1 promoted the microRNA-143 (miR-143) expression and miR-143 could bind to the predicted binding site of UCA1. We then proved the anti-tumor role of miR-143 in PCa. Furthermore, we found that miR-143 displays its role in PCa via modulating the MYO6 expression. In summary, our study demonstrated that UCA1 exerts oncogenes activity in PCa, acting mechanistically by upregulating MYO6 expression through "sponging" miR-143.
引用
收藏
页码:751 / 758
页数:8
相关论文
共 50 条
  • [21] lncRNA UCA1 promotes tumor progression by targeting SMARCD3 in cervical cancer
    An, Lanfen
    Dong, Kejun
    Chi, Shuqi
    Wei, Sitian
    Zhang, Jun
    Yu, Zhicheng
    Zhang, Qian
    Zhang, Tangansu
    Cheng, Shuangshuang
    Shi, Rui
    Jin, Zhishan
    Zhou, Xing
    Zhao, Yingchao
    Wang, Hongbo
    MOLECULAR CARCINOGENESIS, 2024, 63 (03) : 384 - 399
  • [22] LncRNA UCA1 could regulate the progression of neuropathic pain by regulating miR-135a-5p
    Wu, Bingbing
    Zhou, Xiaogang
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2023, 827
  • [23] LncRNA UCA1 promotes vasculogenic mimicry by targeting miR-1-3p in gastric cancer
    Lu, Yida
    Yang, Bo
    Shen, Aolin
    Yu, Kexun
    Ma, MengDi
    Li, Yongxiang
    Wang, Huizhen
    CARCINOGENESIS, 2024, 45 (09) : 658 - 672
  • [24] LncRNA UCA1 elevates the resistance of human leukemia cells to daunorubicin by the PI3K/AKT pathway via sponging miR-613
    Yao, Qiying
    Zhang, Li
    Wang, Yuchuan
    Liu, Junli
    Yang, Liu
    Wang, Yingjie
    BIOSCIENCE REPORTS, 2021, 41 (04)
  • [25] LncRNA UCA1 regulates cervical cancer surviva and EMT occurrence by targeting miR-155
    Yang, T. -J.
    Wang, L.
    Zhang, Y.
    Zheng, J. -D.
    Liu, L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (19) : 9869 - 9879
  • [26] Loss of lncRNA UCA1 ameliorates the injury managed by cerebral ischemia-reperfusion by sponging miR-18a-5p
    Yan, Jingyi
    Gao, Yang
    Huang, Jianyuan
    Gao, Wei
    Li, Yang
    Lin, Baishun
    FOLIA NEUROPATHOLOGICA, 2023, 61 (01) : 77 - 87
  • [27] LncRNA UCA1 promotes migration and invasion in pancreatic cancer cells via the Hippo pathway
    Zhang, Meiting
    Zhao, Yi
    Zhang, Youli
    Wang, Dawei
    Gu, Shuming
    Feng, Wen
    Peng, Wanxin
    Gong, Aihua
    Xu, Min
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2018, 1864 (05): : 1770 - 1782
  • [28] LncRNA UCA1 Accelerates the Progression of Ulcerative Colitis via Mediating the miR-331-3p/BRD4 Axis
    Rao, Jun
    Shao, Lihua
    Lin, Min
    Huang, Jin
    Li Fan
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 2427 - 2435
  • [29] Long non-coding RNA UCA1 upregulates KIF20A expression to promote cell proliferation and invasion via sponging miR-204 in cervical cancer
    He, Qing
    Meng, Jianzhou
    Liu, Shuai
    Zeng, Qiangcheng
    Zhu, Qinghua
    Wei, Zhenlin
    Shao, Yibo
    CELL CYCLE, 2020, 19 (19) : 2486 - 2495
  • [30] LncRNA UCA1 mediates Cetuximab resistance in Colorectal Cancer via the MiR-495 and HGF/c-MET Pathways
    Yuan, Heng-Heng
    Zhang, Xin-Chen
    Wei, Xiao-Li
    Zhang, Wen-Jie
    Du, Xiao-Xue
    Huang, Peng
    Chen, Hao
    Bai, Lu
    Zhang, Hong-Feng
    Han, Yu
    JOURNAL OF CANCER, 2022, 13 (01): : 253 - 267